These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3092231)

  • 1. Comparison of verapamil and nifedipine in thrombosis models.
    Myers AK; Forman G; Torres Duarte AP; Penhos J; Ramwell P
    Proc Soc Exp Biol Med; 1986 Oct; 183(1):86-91. PubMed ID: 3092231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disparate effects of the calcium-channel blockers, nifedipine and verapamil, on alpha 2-adrenergic receptors and thromboxane A2-induced aggregation of human platelets.
    Johnson GJ; Leis LA; Francis GS
    Circulation; 1986 Apr; 73(4):847-54. PubMed ID: 3004784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenosine potentiates the inhibitory effects of calcium channel antagonists on human platelet aggregation induced by thromboxane A2 or U46619.
    Johnson GJ; Leis LA; Francis GS
    Thromb Res; 1990 Jul; 59(1):139-48. PubMed ID: 2399526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of verapamil and diltiazem on aggregatory responses in cat and rabbit platelet rich plasma.
    Lippton HL; Horwitz PM; McNamara DB; Landry AZ; Kadowitz PJ
    Prostaglandins Leukot Med; 1984 Oct; 16(1):121-30. PubMed ID: 6440150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the calcium-entry blocking agent nifedipine on activation of human platelets and comparison with verapamil.
    Han P; Boatwright C; Ardlie NG
    Thromb Haemost; 1983 Aug; 50(2):513-7. PubMed ID: 6314581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Ca2+-antagonistic vasodilators, diltiazem, nifedipine, perhexiline and verapamil, on platelet aggregation in vitro.
    Ono H; Kimura M
    Arzneimittelforschung; 1981; 31(7):1131-4. PubMed ID: 7196762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antithrombogenic in vivo effects of calcium channel blockers in experimental thrombosis in mice.
    Ortega MP; Sunkel C; Priego JG; Statkow PR
    Thromb Haemost; 1987 Jun; 57(3):283-5. PubMed ID: 3660330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium channel blocker treatment of tumor cells induces alterations in the cytoskeleton, mobility of the integrin alpha IIb beta 3 and tumor-cell-induced platelet aggregation.
    Timar J; Chopra H; Rong X; Hatfield JS; Fligiel SE; Onoda JM; Taylor JD; Honn KV
    J Cancer Res Clin Oncol; 1992; 118(6):425-34. PubMed ID: 1377695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of verapamil, diltiazem and nifedipine on some parameters of hemostasis in the rat.
    Pietraszek MH; Chabielska E; Buczko W
    Thromb Res; 1988 Apr; 50(2):325-8. PubMed ID: 3394117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of platelet aggregation by diltiazem. Comparison with verapamil and nifedipine and inhibitory potencies of diltiazem metabolites.
    Kiyomoto A; Sasaki Y; Odawara A; Morita T
    Circ Res; 1983 Feb; 52(2 Pt 2):I115-9. PubMed ID: 6831645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thromboxane in sudden death.
    Myers AK; Ramwell PW
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():81-8. PubMed ID: 3159233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of human platelet aggregation and cytoplasmic calcium response by calcium antagonists: studies with aequorin and quin2.
    Ware JA; Johnson PC; Smith M; Salzman EW
    Circ Res; 1986 Jul; 59(1):39-42. PubMed ID: 3089642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Verapamil is a potent inhibitor of 5-HT-induced platelet aggregation.
    Glusa E; Bevan J; Heptinstall S
    Thromb Res; 1989 Jul; 55(2):239-245. PubMed ID: 2528843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of some calcium antagonists on aggregation by adrenalin and serotonin and on alpha-adrenoceptor radioligand binding in human platelets.
    Vinge E; Andersson TL; Larsson B
    Acta Physiol Scand; 1988 Jul; 133(3):407-16. PubMed ID: 2906509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure of calcium channel blockade to reduce platelet-mediated cyclic flow variations in dogs with coronary stenosis and endothelial injury.
    Beaughard M; Brasset M; John G; Massingham R
    J Cardiovasc Pharmacol; 1995 Oct; 26(4):577-83. PubMed ID: 8569218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benzodiazepines inhibit human platelet activation: comparison of the mechanism of antiplatelet actions of flurazepam and diazepam.
    Romstedt K; Huzoor-Akbar
    Thromb Res; 1985 May; 38(4):361-74. PubMed ID: 2990062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo characterization of combination antitumor chemotherapy with calcium channel blockers and cis-diamminedichloroplatinum(II).
    Onoda JM; Nelson KK; Taylor JD; Honn KV
    Cancer Res; 1989 Jun; 49(11):2844-50. PubMed ID: 2720644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the effects of carvedilol, propranolol, and verapamil on in vitro platelet function in healthy volunteers.
    Gasser JA; Betterridge DJ
    J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S29-34. PubMed ID: 1721976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of nifedipine, verapamil and diltiazem on pulmonary vascular resistance and vasoconstrictors in cats.
    Erdemli O; Hao Q; Cai B; Lippton HL; Hyman A
    Arch Int Pharmacodyn Ther; 1994; 328(2):165-79. PubMed ID: 7535994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of vascular graft thrombosis: role of altered canine platelet sensitivity to thromboxane.
    McGoff MA; Allen BT; Der T; Sicard GA; Santoro SA
    Thromb Res; 1989 Sep; 55(6):695-707. PubMed ID: 2506670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.